Latest Breaking News On - Adrian kemp - Page 5 : comparemela.com

Form 6-K ASTRAZENECA PLC For: Feb 22

Form 6-K ASTRAZENECA PLC For: Feb 22
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomAdrian kempCommission file numberGracell biotechnologies incCompany secretarySecurities exchangeInvestor relations teamSecurities exchange actFile numberRegulationst ruleGracell biotechnologiesAstrazeneca biopharmaceuticalsAnnual reportRare diseasesFor media

AstraZeneca : Transparency Directive - Form 6-K -January 02, 2024 at 10:55 am EST

AstraZeneca : Transparency Directive - Form 6-K -January 02, 2024 at 10:55 am EST
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesAdrian kempCompany on twitter astrazenecaSecurities exchangeInvestor relations teamUnited kingdom financial conduct authority disclosureCommission file numberForeign issuerSecurities exchange actFile numberCrick avenueRegulationst ruleVoting rightsUnited kingdom financial conduct authorityTransparency rule

AstraZeneca : to acquire Gracell, furthering cell therapy ambition across oncology and autoimmune diseases - Form 6-K -December 27, 2023 at 07:13 am EST

a8499x FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Issuer Pursuant to Rule 13a-16 or.

United statesUnited kingdomSusan galbraithGracell fasWilliam caoAdrian kempGracell biotechnologies incInvestor relations teamExchange commissionCompany secretarySecurities exchangeCommission file numberForeign issuerSecurities exchange actFile numberCrick avenue

AstraZeneca : Wainua (eplontersen) granted first-ever regulatory approval in the US for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated amyloidosis - Form 6-K -December 22, 2023 at 06:21 am EST

a7568x FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Issuer Pursuant to Rule 13a-16 or.

United kingdomUnited statesIoni wainuaIsabelle lousadaMichaelj polydefkisAdrian kempInvestor relations teamAmyloidosis research consortiumColumbia university irving medical centerDrug administrationEuropean commissionCompany secretarySecurities exchangeIonis pharmaceuticalsCommission file numberJournal of the american medical association

AstraZeneca : Transaction by Person Discharging Managerial Responsibilities - Form 6-K -December 14, 2023 at 10:24 am EST

a7197w FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Issuer Pursuant to Rule 13a-16 or.

United kingdomUnited statesAnna manzAdrian kempInvestor relations teamSecurities exchangeEuropean union withdrawalCompany on twitter astrazenecaCommission file numberPurchase of astrazenecaForeign issuerSecurities exchange actFile numberCrick avenueRegulationst rulePerson discharging managerial responsibilities